Group develops method of killing cancer cells with antibodies and light
November 7, 2011
by Bob Yirka
in Cancer
(Medical Xpress) -- Traditionally, there are three major ways to combat cancer in people: surgical removal, radiation therapy and chemotherapy. And while all three have been proven to be effective in treating some types of cancer, all three also have unpleasant side effects. Its for this reason that researchers continue to try to find other ways to kill cancer cells. Now, in a paper published in Nature Medicine, a team from the National Cancer Institute in the United States, says that it has developed a type of photoimmunotherapy that combines a light-sensitive dye that has a special chemical in it and antibodies to target and kill cancer cells when light is shined on them.
Photoimmunotherapy has been tried before, but not in this way, in previous research such antibodies were not nearly so target specific, meaning they tended to kill other cells as well. In this latest research, the team was able to use tumor specific antibodies that would attach themselves to the cancer cells, but would remain dormant. It was only when the same cancer cells were also exposed to a chemical called IR700 and then exposed to light that the antibodies went to work killing the cancer cells.
In their lab studies, the team inserted a type of skin cancer into the skin on the back of a mouse; when given the drug and then exposed to light, the research team found that the size of the tumor in the mouse was significantly reduced compared to control mice. They also found that other cells around the tumor were unaffected and that there didnt appear to be any toxic reactions to the treatment.
Its not yet known if the procedure would work in humans, but further research is likely to be done in a lot of areas, likely including other types of animals before tests can be conducted with human volunteers. Also, research is continuing to see if it might be possible to use antibodies to deliver other sorts of cancer killing agents, such as radiation.
If such types of photoimmunotherapy prove workable, millions of people the world over might be spared the pain of surgery and/or the harmful side effects of radiation and chemotherapy.
More information: Cancer cellselective in vivo near infrared photoimmunotherapy targeting specific membrane molecules, Nature Medicine (2011) doi:10.1038/nm.2554
Abstract
Three major modes of cancer therapy (surgery, radiation and chemotherapy) are the mainstay of modern oncologic therapy. To minimize the side effects of these therapies, molecular-targeted cancer therapies, including armed antibody therapy, have been developed with limited success. In this study, we have developed a new type of molecular-targeted cancer therapy, photoimmunotherapy (PIT), that uses a target-specific photosensitizer based on a near-infrared (NIR) phthalocyanine dye, IR700, conjugated to monoclonal antibodies (mAbs) targeting epidermal growth factor receptors. Cell death was induced immediately after irradiating mAb-IR700bound target cells with NIR light. We observed in vivo tumor shrinkage after irradiation with NIR light in target cells expressing the epidermal growth factor receptor. The mAb-IR700 conjugates were most effective when bound to the cell membrane and produced no phototoxicity when not bound, suggesting a different mechanism for PIT as compared to conventional photodynamic therapies. Target-selective PIT enables treatment of cancer based on mAb binding to the cell membrane.
© 2011 PhysOrg.com
-
Pancreas betrayed by 'double agent'
May 30, 2011 |
not rated yet |
0
-
Artificial antibodies hold promise for fighting cancer, other diseases
Oct 26, 2010 |
not rated yet |
0
-
Stem cells, potential source of cancer-fighting T cells
Sep 20, 2011 |
not rated yet |
0
-
UV light improving chances of fighting cancer
Oct 30, 2007 |
not rated yet |
0
-
Polymer Nanoparticle Kills Tumors
Jan 12, 2006 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
-
Marie Curie's leukemia
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Team finds mechanism linking key inflammatory marker to cancer
In a new study described in the journal Oncogene, researchers reveal how a key player in cell growth, immunity and the inflammatory response can be transformed into a primary contributor to tumor growth.
Cancer
1 hour ago |
not rated yet |
0
|
Study of young Israelis emphasizes need for avoidance of sun exposure for the very young
A new study conducted using extensive medical records of over one million Israeli adolescents before military service shows clearly how exposure to the Israeli sun of young, light-skinned children increases substantially ...
Cancer
3 hours ago |
not rated yet |
0
Genetic diversity within tumors predicts outcome in head and neck cancer
A new measure of the heterogeneity – the variety of genetic mutations – of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer. In the May 20 issue ...
Cancer
7 hours ago |
not rated yet |
0
Molecular marker from pancreatic 'juices' helps identify pancreatic cancer
Researchers at Mayo Clinic have developed a promising method to distinguish between pancreatic cancer and chronic pancreatitis—two disorders that are difficult to tell apart. A molecular marker obtained from pancreatic ...
Cancer
7 hours ago |
not rated yet |
0
New smartphone application improves colonoscopy preparation
The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...
Cancer
May 19, 2013 |
not rated yet |
0
Neurons that can multitask greatly enhance the brain's computational power, study finds
Over the past few decades, neuroscientists have made much progress in mapping the brain by deciphering the functions of individual neurons that perform very specific tasks, such as recognizing the location ...
Anabolic steroids may affect future mental health
There is a link between use of anabolic-androgenic steroids and reduced mental health later in life. This is the main conclusion of a new study on elite male strength athletes that researchers from the University of Gothenburg ...
Half time warm-ups boost athletic performance
High-intensity, short duration warm up activities at half time intervals boost athletic performance, a study of soccer players has found.
Youth bullying because of perceived sexual orientation widespread and damaging
(Medical Xpress)—Bullying because of perceived sexual orientation is prevalent among school-aged youths, according to a study led by Donald Patrick, professor of health services at the UW School of Public ...
New study identifies risk factors for depression among COPD patients
Patients suffering from chronic obstructive pulmonary disease (COPD) typically suffer from depression more frequently than those without COPD, resulting in higher levels of disability and illness and increasing the overall ...
Immune protein could stop diabetes in its tracks
Melbourne researchers have identified an immune protein that has the potential to stop or reverse the development of type 1 diabetes in its early stages, before insulin-producing cells have been destroyed.
Nov 07, 2011
Rank: not rated yet